[HTML][HTML] Primary bone lymphoma: a review of the literature with emphasis on histopathology and histogenesis

T Kanavos, E Birbas, A Papoudou-Bai, E Hatzimichael… - Diseases, 2023 - mdpi.com
Primary bone lymphoma (PBL) is a rare neoplasm of malignant lymphoid cells presenting
with one or more bone lesions without nodal or other extranodal involvement. It accounts for …

[HTML][HTML] Classifying germinal center derived lymphomas—Navigate a complex transcriptional landscape

H Loeffler-Wirth, M Kreuz, M Schmidt, G Ott, R Siebert… - Cancers, 2022 - mdpi.com
Simple Summary Germinal center-derived B-cell lymphomas constitute a very
heterogeneous group of neoplasms with diverse clinical presentations, prognoses, and …

[HTML][HTML] Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma

D Xiong, X Wei, W Huang, J Zheng, R Feng - Aging (Albany NY), 2024 - ncbi.nlm.nih.gov
Background/Aims: Diffuse large B-cell lymphoma (DLBCL), the most common subtype of
non-Hodgkin lymphoma, has significant prognostic heterogeneity. This study aimed to …

Advances in proteomics in diffuse large B‑cell lymphoma

Z Guo, C Wang, X Shi, Z Wang, J Tao… - Oncology …, 2024 - spandidos-publications.com
Diffuse large B‑cell lymphoma (DLBCL) is the most common pathological type of non‑
Hodgkin's lymphoma. Although the development of monoclonal antibodies, small‑molecule …

Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis

M Zhao, L Wang, X Wang, J He, K Yu, D Li - Tumori Journal, 2024 - journals.sagepub.com
The microenvironment of diffuse large B-cell lymphoma (DLBCL) is composed of various
components, including immune cells and immune checkpoints, some of which have been …

[HTML][HTML] Pareto task inference analysis reveals cellular trade-offs in diffuse large B-Cell lymphoma transcriptomic data

J Blais, J Jeukens - Frontiers in Systems Biology, 2024 - frontiersin.org
One of the main challenges in cancer treatment is the selection of treatment resistant clones
which leads to the emergence of resistance to previously efficacious therapies. Identifying …

Can the Pareto optimality theory reveal cellular trade-offs in diffuse large B-Cell lymphoma transcriptomic data?

J Blais, J Jeukens - 2023 - researchsquare.com
One of the main challenges in cancer treatment is the selection of treatment resistant clones
which leads to the emergence of resistance to previously efficacious therapies. Identifying …

[PDF][PDF] Classifying Germinal Center Derived Lymphomas—Navigate a Complex Transcriptional Landscape. Cancers 2022, 14, 3434

H Loeffler-Wirth, M Kreuz, M Schmidt, G Ott, R Siebert… - 2022 - researchgate.net
Classification of lymphoid neoplasms is based mainly on histologic, immunologic, and
(rarer) genetic features. It has been supplemented by gene expression profiling (GEP) in the …

Classifying Germinal Center Derived Lymphomas

H Loeffler-Wirth, M Kreuz, M Schmidt, G Ott, R Siebert… - 2022 - ul.qucosa.de
Abstract (EN) Classification of lymphoid neoplasms is based mainly on histologic,
immunologic, and (rarer) genetic features. It has been supplemented by gene expression …